CN1147397A - Chinese patent medicine for treating various cancers and tumors - Google Patents
Chinese patent medicine for treating various cancers and tumors Download PDFInfo
- Publication number
- CN1147397A CN1147397A CN96109333A CN96109333A CN1147397A CN 1147397 A CN1147397 A CN 1147397A CN 96109333 A CN96109333 A CN 96109333A CN 96109333 A CN96109333 A CN 96109333A CN 1147397 A CN1147397 A CN 1147397A
- Authority
- CN
- China
- Prior art keywords
- parts
- herba
- root
- pharmaceutical composition
- schindl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 206010028980 Neoplasm Diseases 0.000 title claims abstract description 38
- 239000003814 drug Substances 0.000 title claims abstract description 32
- 239000008194 pharmaceutical composition Substances 0.000 claims abstract description 18
- 240000004371 Panax ginseng Species 0.000 claims abstract description 12
- 235000002789 Panax ginseng Nutrition 0.000 claims abstract description 12
- 241001290726 Peristrophe Species 0.000 claims abstract description 12
- 235000008434 ginseng Nutrition 0.000 claims abstract description 12
- 239000002994 raw material Substances 0.000 claims abstract description 10
- 239000000203 mixture Substances 0.000 claims abstract description 7
- 206010042772 syncope Diseases 0.000 claims abstract description 6
- 241000218211 Maclura Species 0.000 claims abstract description 3
- 239000002552 dosage form Substances 0.000 claims abstract 3
- 241001166994 Kummerowia striata Species 0.000 claims description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 15
- 244000025254 Cannabis sativa Species 0.000 claims description 11
- 244000153234 Hibiscus abelmoschus Species 0.000 claims description 11
- 235000009815 Momordica Nutrition 0.000 claims description 11
- 241000218984 Momordica Species 0.000 claims description 11
- 240000000203 Salix gracilistyla Species 0.000 claims description 11
- 230000010159 dioecy Effects 0.000 claims description 11
- 201000011510 cancer Diseases 0.000 claims description 9
- 239000007788 liquid Substances 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 7
- 239000002775 capsule Substances 0.000 claims description 6
- 238000004806 packaging method and process Methods 0.000 claims description 4
- 229940079593 drug Drugs 0.000 claims description 3
- 238000011275 oncology therapy Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 10
- 206010006187 Breast cancer Diseases 0.000 abstract description 4
- 208000026310 Breast neoplasm Diseases 0.000 abstract description 4
- 208000005016 Intestinal Neoplasms Diseases 0.000 abstract description 4
- 208000005718 Stomach Neoplasms Diseases 0.000 abstract description 4
- 206010017758 gastric cancer Diseases 0.000 abstract description 4
- 201000002313 intestinal cancer Diseases 0.000 abstract description 4
- 201000011549 stomach cancer Diseases 0.000 abstract description 4
- 241000411851 herbal medicine Species 0.000 abstract description 3
- 208000017520 skin disease Diseases 0.000 abstract description 2
- 241000196324 Embryophyta Species 0.000 abstract 1
- 241000402754 Erythranthe moschata Species 0.000 abstract 1
- 244000302512 Momordica charantia Species 0.000 abstract 1
- 235000009811 Momordica charantia Nutrition 0.000 abstract 1
- 235000009812 Momordica cochinchinensis Nutrition 0.000 abstract 1
- 235000018365 Momordica dioica Nutrition 0.000 abstract 1
- 244000178706 Ornithopus sativus Species 0.000 abstract 1
- 241000691155 Pteris multifida Species 0.000 abstract 1
- 244000153955 Reynoutria sachalinensis Species 0.000 abstract 1
- 235000003202 Reynoutria sachalinensis Nutrition 0.000 abstract 1
- 241000972149 Urochloa mosambicensis Species 0.000 abstract 1
- 208000002495 Uterine Neoplasms Diseases 0.000 abstract 1
- 201000007270 liver cancer Diseases 0.000 abstract 1
- 208000014018 liver neoplasm Diseases 0.000 abstract 1
- JZWFDVDETGFGFC-UHFFFAOYSA-N salacetamide Chemical group CC(=O)NC(=O)C1=CC=CC=C1O JZWFDVDETGFGFC-UHFFFAOYSA-N 0.000 abstract 1
- 206010046766 uterine cancer Diseases 0.000 abstract 1
- 230000003203 everyday effect Effects 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 4
- 201000008275 breast carcinoma Diseases 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- 208000017897 Carcinoma of esophagus Diseases 0.000 description 2
- 206010009944 Colon cancer Diseases 0.000 description 2
- 206010030155 Oesophageal carcinoma Diseases 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 238000002512 chemotherapy Methods 0.000 description 2
- 208000029742 colonic neoplasm Diseases 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 201000005619 esophageal carcinoma Diseases 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 208000010125 myocardial infarction Diseases 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 208000012991 uterine carcinoma Diseases 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- 235000005637 Brassica campestris Nutrition 0.000 description 1
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 description 1
- 240000003259 Brassica oleracea var. botrytis Species 0.000 description 1
- 241001301148 Brassica rapa subsp. oleifera Species 0.000 description 1
- 206010048768 Dermatosis Diseases 0.000 description 1
- GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 102000015696 Interleukins Human genes 0.000 description 1
- 108010063738 Interleukins Proteins 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- 239000003005 anticarcinogenic agent Substances 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- DQLATGHUWYMOKM-UHFFFAOYSA-L cisplatin Chemical compound N[Pt](N)(Cl)Cl DQLATGHUWYMOKM-UHFFFAOYSA-L 0.000 description 1
- 229960004316 cisplatin Drugs 0.000 description 1
- 238000003748 differential diagnosis Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 229960002949 fluorouracil Drugs 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000021059 hard food Nutrition 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- -1 impact Substances 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000003978 infusion fluid Substances 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 201000000849 skin cancer Diseases 0.000 description 1
- 201000008261 skin carcinoma Diseases 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000009333 tian-xian Substances 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention relates to a pharmaceutical composition for treating various cancers and tumors, in particular to a pure traditional Chinese medicine composition for treating various cancers and tumors, which is prepared by taking plant Chinese herbal medicines as raw materials, comprises musk, black syncope, Japanese peristrophe root, common jasminorange herb, bird's foot, giant knotweed, herringbone grass, Chinese brake herb root, mountain balsam pear, salicyl, cudrania root and Korean ginseng, can be prepared into various dosage forms, and has special treatment effects on skin diseases, breast cancer, uterine cancer, gastric cancer, liver cancer, intestinal cancer and the like.
Description
The present invention relates to a kind of pharmaceutical composition for the treatment of various cancers and tumor, particularly a kind of is the various cancers of treatment made of raw material and the pure Chinese medicine composition of tumor with the vegetable Chinese herbal medicine, and dermatosis, breast carcinoma, uterus carcinoma, gastric cancer, hepatocarcinoma, intestinal cancer etc. are had special therapeutic effect.
According to World Health Organization (WHO) statistics, the sickness rate of various cancers and tumor is the trend, particularly hepatocarcinoma that rise year by year, gastric cancer, breast carcinoma, uterus carcinoma, intestinal cancer etc. and human health is threatened maximum.Up to the present, still there is not a kind of specially good effect good medicine for the treatment of cancer and tumor in the world, present Therapeutic Method be to early, mid-term cancer and tumor patient carry out operative treatment, chemotherapy, the bonded complex treatment measure of Chinese medicine and western medicine, although obtained certain curative effect, it also only is the effect of playing relief of symptoms, for the late malignant tumour patient, lack especially effectively Therapeutic Method.Anticancer Western medicine commonly used has interferon, interleukin, cisplatin, 5-fluorouracil etc., and the effect that these medicines have is undesirable, and the side effect that has is too big; Chinese medicine anticarcinogen commonly used generally is a medicine targetedly, is medicine at alimentary tract cancer as FUFANG TIANXIAN WAN, and shortage can be treated the medicine of multiple cancer and tumor at present.
The object of the invention provides a kind of Chinese medicine pharmaceutical composition that can effectively treat various cancers and tumor.
Technical scheme of the present invention is to the pathogeny of generation, development and the transfer of cancer and tumor and Therapeutic Principle's understanding according to motherland's traditional medicine, gain knowledge in conjunction with modern pharmacology, from motherland's medical treasure-house, filter out the development (recurrence, transfer) that has no side effect, can suppress tumor, safeguard the allomeric function of body, and can blood circulation promoting and blood stasis dispelling, the vegetable Chinese herbal medicine of regulating QI to relieve pain, hard masses softening and resolving, heat-clearing and toxic substances removing, strengthening the body resistance, press the tcm theory prescription, develop anticancer pharmaceutical composition of the present invention.
The composition of pharmaceutical composition of the present invention is counted as follows by weight ratio:
Moschus 6-12 part
The crow 6-15 part of fainting
Herba Peristrophes grass roots 15-25 part
Herba Senecionis Scandentis 15-25 part
NIAOBUTA 20-30 part
Rhizoma Polygoni Cuspidati 6-15 part
Kummerowia striata (Thunb.) Schindl 20-30 part
Herba Pteridis Multifidae root 35-45 part
Dioecism momordica root 6-12 part
Bigcatkin willow 25-35 part
Radix Cudraniae 20-30 part
Korean Ginseng 25-35 part
The preferred weight proportioning of pharmaceutical composition each component of the present invention is:
Moschus 7-10 part
The crow 8-12 part of fainting
Herba Peristrophes grass roots 18-22 part
Herba Senecionis Scandentis 18-22 part
NIAOBUTA 22-28 part
Rhizoma Polygoni Cuspidati 8-12 part
Kummerowia striata (Thunb.) Schindl 22-28 part
Herba Pteridis Multifidae root 38-42 part
Dioecism momordica root 8-12 part
Bigcatkin willow 28-32 part
Radix Cudraniae 22-28 part
Korean Ginseng 28-32 part
The optimum weight proportioning of pharmaceutical composition of the present invention is:
8 parts in Moschus
Crow is fainted 10 parts
20 parts of Herba Peristrophes grass roots
20 parts of Herba Senecionis Scandentis
25 parts of NIAOBUTA
10 parts of Rhizoma Polygoni Cuspidati
25 parts of Kummerowia striata (Thunb.) Schindl
40 parts of Herba Pteridis Multifidae roots
10 parts of dioecism momordica roots
30 parts of bigcatkin willows
25 parts of Radix Cudraniaes
30 parts of Korean Ginseng
Above-mentioned various components, all on the books in " Chinese medicine dictionary ", all can realize purpose of the present invention with any medicine of described title record, wherein the preferred SANYE Kummerowia striata (Thunb.) Schindl of Kummerowia striata (Thunb.) Schindl.
Pharmaceutical composition of the present invention can be prepared into any medicament according to the pharmaceutical preparation technology of routine, as oral liquid, capsule, tablet, pill, powder, impact, unguentum, infusion solution etc.
The capsule preparation method thereof of medicine of the present invention is:
According to the composition of pharmaceutical composition of the present invention, choose raw material, oven dry is pulverized, and crosses 100 mesh sieves, and is encapsulated, promptly.
Perhaps,
According to the composition of pharmaceutical composition of the present invention, choose raw material, decoct with water twice, for the first time amount of water make a living dose 3-5 doubly, decocted 1-2 hour, for the second time make a living 2-4 times of dose of amount of water, decocted 0.5-1.5 hour, merge decoction liquor twice, filter, be condensed into dry extract, be ground into fine powder, encapsulated, that is, and every capsules 2 grams.
The preparation method of medicine oral liquid of the present invention is:
According to the composition of pharmaceutical composition of the present invention, choose raw material, soak 2 hours after, decoct three times, for the first time amount of water make a living dose 3-5 doubly, decocted 1-2 hour, for the second time amount of water make a living dose 2-4 doubly, decocted 0.5-1.5 hour, for the third time make a living 2-3 times of dose of amount of water, decocted 0.5-1 hour, merge three times decoction liquor, decocted again 1 hour, filter, sterilized 30 minutes for 100 ℃, sealed packaging promptly.
Medicine of the present invention has the effect of blood circulation promoting and blood stasis dispelling, regulating QI to relieve pain, harmonizing the liver and spleen, strengthening the body resistance, makes the doing well,improving of tumour patient, and tumor is progressively dwindled and disappeared, and can suppress neoplasm metastasis, strengthens patient's immunity of organisms, improves the survival rate of tumor patient.
An important feature of medicine of the present invention is to pass through function of spleen and stomach regulating, to protect the foundation of acquired constitution, the resistance against diseases of enhancing body, in the hope of strengthening vital QI to eliminate pathogenic factors, decapacitation is eliminating evil sends an expedition against outside the local tumor, can also regulate the allomeric function of body, make certain cancers patient's the state of an illness obtain in various degree alleviation, indivedual cancer patient's symptoms are disappeared unexpectedly; Second characteristic of the present invention are principles of executing to control according to differential diagnosis in tcm, become in the present invention on the basis of medicament, different onset mechanism at various cancers and tumor is added and subtracted, and can to hepatocarcinoma, gastric cancer, esophageal carcinoma, skin carcinoma, breast carcinoma, intestinal cancer etc. curative effect preferably be arranged respectively.
The using method of medicine of the present invention is:
Early, mid-term tumor patient, oral liquid secondary every day, each 50 milliliters, capsule secondary every day, each 2, two months is a course of treatment.The late malignant tumour patient, oral liquid every day three times, each 80 milliliters, capsule every day 3 times, each 4, one month is a course of treatment.Symptom and sign before, during and after should observing the patient respectively and taking medicine, hepatogastric function, the tumor size, sign variation etc., patient is at period in a medicine, must guard against edible raw food, hard food, and beef or mutton, egg, Radix hemerocalis plicatae, cauliflower, Brassica campestris L etc.
Treatment example 1
The man, 58 years old, suffer from esophageal carcinoma, through how tame hospital chemotherapy, treat equal unsatisfactory curative effect, earn a bare living by transfusion, the health extremely feeble after take medicine of the present invention, every day 3 times, each 80 milliliters, recover feed after one month, but existing patient is with normal activity.
Treatment example 2
The man, 64 years old, colon cancer patient, suffer from myocardial infarction and serious diabetes simultaneously, the excision that can not undergo surgery is after take medicine oral liquid of the present invention, every day 3 times, each 80 milliliters, after serveing on 40 days, patient's colon cancer is controlled, focus is dwindled, free movement of the bowels, and myocardial infarction and diabetic symptom are also seen improvement.
Embodiment 1
Prescription:
Moschus 6 grams
Crow faint 6 the gram
Herba Peristrophes grass roots 15 grams
Herba Senecionis Scandentis 15 grams
NIAOBUTA 20 grams
Rhizoma Polygoni Cuspidati 6 grams
Kummerowia striata (Thunb.) Schindl 20 grams
Herba Pteridis Multifidae root 35 grams
Dioecism momordica root 6 grams
Bigcatkin willow 25 grams
Radix Cudraniae 20 grams
Korean Ginseng 25 grams
Method for making:
Choose raw material, soak 2 hours after, decoct three times, for the first time make a living 3 times of dose of amount of water decocted 1 hour, the second time make a living 2 times of dose of amount of water, decocted 0.5 hour, make a living 2 times of dose of amount of water decocted 0.5 hour for the third time, merged three times decoction liquor, decocted again 1 hour, filter, sterilized 30 minutes for 100 ℃, sealed packaging promptly.
Embodiment 2
Prescription:
Moschus 12 grams
Crow faint 15 the gram
Herba Peristrophes grass roots 25 grams
Herba Senecionis Scandentis 25 grams
NIAOBUTA 30 grams
Rhizoma Polygoni Cuspidati 15 grams
Kummerowia striata (Thunb.) Schindl 30 grams
Herba Pteridis Multifidae root 45 grams
Dioecism momordica root 12 grams
Bigcatkin willow 35 grams
Radix Cudraniae 30 grams
Korean Ginseng 35 grams
Method for making:
Choose raw material, soak 2 hours after, decoct three times, for the first time make a living 5 times of dose of amount of water decocted 2 hours, the second time make a living 4 times of dose of amount of water, decocted 1.5 hours, make a living 2 times of dose of amount of water decocted 0.5 hour for the third time, merged three times decoction liquor, decocted again 1 hour, filter, sterilized 30 minutes for 100 ℃, sealed packaging promptly.
Embodiment 3
Prescription:
Moschus 8 grams
Crow faint 10 the gram
Herba Peristrophes grass roots 20 grams
Herba Senecionis Scandentis 20 grams
NIAOBUTA 25 grams
Rhizoma Polygoni Cuspidati 10 grams
Kummerowia striata (Thunb.) Schindl 25 grams
Herba Pteridis Multifidae root 40 grams
Dioecism momordica root 10 grams
Bigcatkin willow 30 grams
Radix Cudraniae 25 grams
Korean Ginseng 30 grams
Method for making:
Choose raw material, select removal impurity, oven dry is pulverized, and crosses 100 mesh sieves, and is encapsulated, every 2 gram, promptly.
Embodiment 4
Prescription:
Moschus 10 grams
Crow faint 12 the gram
Herba Peristrophes grass roots 22 grams
Herba Senecionis Scandentis 22 grams
NIAOBUTA 28 grams
Rhizoma Polygoni Cuspidati 12 grams
Kummerowia striata (Thunb.) Schindl 28 grams
Herba Pteridis Multifidae root 42 grams
Dioecism momordica root 12 grams
Bigcatkin willow 32 grams
Radix Cudraniae 28 grams
Korean Ginseng 32 grams
Method for making:
Choose raw material, select removal impurity, oven dry is pulverized, and crosses 100 mesh sieves, and is encapsulated, every 2 gram, promptly.
Claims (7)
1, a kind of pharmaceutical composition for the treatment of cancer and tumor is characterized in that it is made up of following components in weight percentage:
Moschus 6-12 part
The crow 6-15 part of fainting
Herba Peristrophes grass roots 15-25 part
Herba Senecionis Scandentis 15-25 part
NIAOBUTA 20-30 part
Rhizoma Polygoni Cuspidati 6-15 part
Kummerowia striata (Thunb.) Schindl 20-30 part
Herba Pteridis Multifidae root 35-45 part
Dioecism momordica root 6-12 part
Bigcatkin willow 25-35 part
Radix Cudraniae 20-30 part
Korean Ginseng 25-35 part
2,, it is characterized in that the weight proportion of each component is according to the pharmaceutical composition of claim 1:
Moschus 7-10 part
The crow 8-12 part of fainting
Herba Peristrophes grass roots 18-22 part
Herba Senecionis Scandentis 18-22 part
NIAOBUTA 22-28 part
Rhizoma Polygoni Cuspidati 8-12 part
Kummerowia striata (Thunb.) Schindl 22-28 part
Herba Pteridis Multifidae root 38-42 part
Dioecism momordica root 8-12 part
Bigcatkin willow 28-32 part
Radix Cudraniae 22-28 part
Korean Ginseng 28-32 part
3,, it is characterized in that the weight proportion of each component is according to the pharmaceutical composition of claim 1:
8 parts in Moschus
Crow is fainted 10 parts
20 parts of Herba Peristrophes grass roots
20 parts of Herba Senecionis Scandentis
25 parts of NIAOBUTA
10 parts of Rhizoma Polygoni Cuspidati
25 parts of Kummerowia striata (Thunb.) Schindl
40 parts of Herba Pteridis Multifidae roots
10 parts of dioecism momordica roots
30 parts of bigcatkin willows
25 parts of Radix Cudraniaes
30 parts of Korean Ginseng
4,, it is characterized in that described Kummerowia striata (Thunb.) Schindl is the SANYE Kummerowia striata (Thunb.) Schindl according to the pharmaceutical composition of claim 1 or 2 or 3.
5, according to the pharmaceutical composition of claim 1 or 2 or 3, the dosage form that it is characterized in that this medicine is any acceptable clinically medicament.
6, according to the pharmaceutical composition of claim 5, the dosage form that it is characterized in that this medicine is capsule or oral liquid.
7, a kind of method for preparing the cancer therapy drug oral liquid is characterized in that this method comprises:
Moschus 6-12 part
The crow 6-15 part of fainting
Herba Peristrophes grass roots 15-25 part
Herba Senecionis Scandentis 15-25 part
NIAOBUTA 20-30 part
Rhizoma Polygoni Cuspidati 6-15 part
Kummerowia striata (Thunb.) Schindl 20-30 part
Herba Pteridis Multifidae root 35-45 part
Dioecism momordica root 6-12 part
Bigcatkin willow 25-35 part
Radix Cudraniae 20-30 part
Korean Ginseng 25-35 part
According to the composition of aforementioned pharmaceutical compositions, choose raw material, soak 2 hours after, decoct three times, for the first time amount of water make a living dose 3-5 doubly, decocted 1-2 hour, for the second time amount of water make a living dose 2-4 doubly, decocted 0.5-1.5 hour, for the third time make a living 2-3 times of dose of amount of water, decocted 0.5-1 hour, merge three times decoction liquor, decocted again 1 hour, filter, sterilized 30 minutes for 100 ℃, sealed packaging promptly.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN96109333A CN1059333C (en) | 1996-09-20 | 1996-09-20 | Chinese patent medicine for treating various cancers and tumors |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN96109333A CN1059333C (en) | 1996-09-20 | 1996-09-20 | Chinese patent medicine for treating various cancers and tumors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1147397A true CN1147397A (en) | 1997-04-16 |
| CN1059333C CN1059333C (en) | 2000-12-13 |
Family
ID=5120337
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN96109333A Expired - Fee Related CN1059333C (en) | 1996-09-20 | 1996-09-20 | Chinese patent medicine for treating various cancers and tumors |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1059333C (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1572223A4 (en) * | 2002-12-17 | 2007-03-21 | Avon Prod Inc | Use of active extracts to improve the appearance of skin, lips, hair and/or nails |
| CN101229348B (en) * | 2008-01-30 | 2010-09-29 | 薛福社 | Chinese traditional medicine compounds for treating tumour and preparing method thereof |
| CN1935228B (en) * | 2006-06-30 | 2011-07-27 | 杨雄志 | Chinese medicine composition for preventing and treating breast cancer and its preparation method |
| CN103610063A (en) * | 2013-12-05 | 2014-03-05 | 成都乾唐农业科技有限责任公司 | Kenneth Lonergan marrow mixture and preparation method thereof |
-
1996
- 1996-09-20 CN CN96109333A patent/CN1059333C/en not_active Expired - Fee Related
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1572223A4 (en) * | 2002-12-17 | 2007-03-21 | Avon Prod Inc | Use of active extracts to improve the appearance of skin, lips, hair and/or nails |
| CN1935228B (en) * | 2006-06-30 | 2011-07-27 | 杨雄志 | Chinese medicine composition for preventing and treating breast cancer and its preparation method |
| CN101229348B (en) * | 2008-01-30 | 2010-09-29 | 薛福社 | Chinese traditional medicine compounds for treating tumour and preparing method thereof |
| CN103610063A (en) * | 2013-12-05 | 2014-03-05 | 成都乾唐农业科技有限责任公司 | Kenneth Lonergan marrow mixture and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1059333C (en) | 2000-12-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1084206C (en) | Cancer treating medicine and its preparation | |
| CN1895619A (en) | Chinese-medicinal composition for preventing and treating liver disease and its preparation | |
| CN1290550C (en) | Chinese medicine composition for treating rheumatism, rheumatoid, hyperosteogeny and fracture and preparing method thereof | |
| CN1966067A (en) | Medicament for treating aplastic anemia | |
| CN1250264C (en) | Capsule for curing hyperplasia of mammary glands and its preparation method | |
| CN1823995A (en) | New medicine for treating malignant tumour | |
| CN1478508A (en) | Chinese medicinal composition for treating fatty liver and its preparation method | |
| CN1111043C (en) | Medicine for protrusion of lumber vertebral disc and its preparation | |
| CN1147397A (en) | Chinese patent medicine for treating various cancers and tumors | |
| CN1990033A (en) | Drug for treating hypertension, dense blood and arteriosclerosis | |
| CN1544032A (en) | Anticancer Chinese traditional extracts and preparation process and application thereof | |
| CN1054541C (en) | Traditional Chinese medicine for treating mastosis | |
| CN1140071A (en) | Anticancer drug and preparing method thereof | |
| CN1191849C (en) | Chinese medicine for treating breast disease | |
| CN1254267C (en) | Medicine for treating gastral cavity pain and its preparation method | |
| CN1876112A (en) | A medicine for treating gastric disease and preparation method thereof | |
| CN1045892C (en) | Chinese medicine Guanxintong for preventing and curing coronary heart disease and angina pectoris, and producing process thereof | |
| CN101032540A (en) | Medicine composition for curing arthritis and the preparing method and purpose thereof | |
| CN1569095A (en) | Medicine for treating cerebral infarction | |
| CN1304045C (en) | Arthralgia removing pills and their preparation | |
| CN1207012C (en) | Medicine for treating digestive system disease and tumor and preparation method thereof | |
| CN1101209C (en) | Medicine for treating digestive tract diseases | |
| CN1416879A (en) | Antilipemic Chinese medicine | |
| CN1304043C (en) | Longhedan pills and their preparation | |
| CN100340285C (en) | Medicine for treating gallstone and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |